HUMAN MEDICINES EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR): DARUNAVIR MYLAN, DARUNAVIR, HIV INFECTIONS, DATE OF AUTHORISATION: 03/01/2017, REVISION: 8, STATUS: AUTHORISED
(AGENPARL) – LONDON (UNITED KINGDOM), mar 16 febbraio 2021 Darunavir, co-administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (HIV-1) infection. Darunavir Mylan tablets may be used to provide suitable dose regimens: For the treatment of......